Blueprint is an indoor cannabis flower and genetics brand cofounded by cultivator Jordan Aguilar with Joe Stanger and Tom Sheridan. The first commercial lineup launched in California in September 2021 after roughly a year of work on Triple Lindy, P90 and Jesus Shuttlesworth. The brand now lists licensed-market availability in California, Florida, New Jersey and Arizona.
The three founders
Aguilar spent more than a decade working from entry-level cultivation into leadership at Connected Cannabis Co. and Alien Labs, where he handled Gelato phenotypes and other major indoor cultivars. That experience shaped Blueprint’s cultivation and selection program. Independent interviews identify Stanger and Sheridan as the other cofounders, though the current official site does not publish detailed biographies for either.
The name expresses the founders’ belief that consistent flower starts with a repeatable cultivation system and clear audience for each cultivar. The official “pillars” are science, technology, imagination and experience; these are operating principles, not evidence that a product is clinically superior.
Original strains and current genetics
The launch trio was Triple Lindy, P90 and Jesus Shuttlesworth. Triple Lindy is currently listed as OZK × Gelato 41, while P90 is GG4 × Gelato 41. The expanded library includes Purple Dinosaur, Chef, Poison, Light Switch, OG, The Baker, Lemonfeen, POG Juice, Woogity, Limez, The Mailman and Peaches, among other rotating selections.
Blueprint sells premium flower through licensed partners and also sells feminized seeds for selected genetics, including Triple Lindy and P90. Seeds are a separate, federally and locally sensitive product category; germination and cultivation legality depend on the buyer’s jurisdiction.
Triple Lindy’s documented Zalympix record
Zalympix’s official winners archive records Triple Lindy first overall and second for taste in the inaugural 2021 California Winter event. In the 2022 California championships, it placed third overall and won the Most Potent/Heaviest Hitting and Gassiest Flower distinctions.
Blueprint’s redesigned homepage currently labels Triple Lindy as “Greenwolf Winter Zalympix 2024” with first overall, first most potent and second taste. Those placements align closely with results spread across the 2021 and 2022 official archive, but the date does not. This profile follows Zalympix’s own year-by-year record and flags the website inconsistency instead of creating a new 2024 win.
Redline selection program
Redline gives selected budtenders, reviewers and consumers access to pre-market phenotypes. Each jar links to a feedback form, and candidates move through Early Look, Serious Contender, Final Review and Chosen stages. The program adds structured outside feedback to internal phenotype selection.
It is still a company-run ambassador and sampling program, not an independent blind trial. Feedback can inform a launch but does not replace compliance testing or prove that a future commercial batch will match the sample.
Four-state footprint
The official site lists California, Florida, New Jersey and Arizona. Florida availability is tied to Cookies dispensaries, while other states use licensed production and retail partners. Blueprint does not claim to own a dispensary chain; the store locator and local menus should be used for current inventory.
Because cannabis cannot be moved through ordinary interstate commerce, “the same strain” in four states may be cultivated by different licensees from shared genetics or brand standards. Batch labels identify the actual producer.
Press, products and limits
Blueprint has received cannabis-media coverage for Aguilar’s cultivation history, the 2021 launch and Triple Lindy’s immediate competition performance. Its direct e-commerce catalog sells seeds and apparel, not THC flower across state lines. Fresh research did not establish a separate corporate award ledger beyond the product-level Zalympix record.
The High Rise read
Blueprint’s real profile is stronger than its old generic “17 strains” summary: three founders, a September 2021 debut, a cultivation lineage through Connected and Alien Labs, a documented award strain, a public pre-market program and a four-state licensing footprint. Accuracy also requires correcting the brand site’s conflicting Zalympix year and distinguishing genetics from local production.